In human clinical medicine, recombinant G-CSF is used as a biophylatic agent to specifically induce granulopoiesis in patients with chemotherapy- and radiation-induced neutropenia to prevent bacterial and fungal infections (66). Here, CSF3 is linked to Decreased total neutrophil count.